Printer Friendly

BIO-VASCULAR REPORTS GAINS IN FIRST QUARTER SALES, NET INCOME

 ST. PAUL, Minn., Feb. 22 /PRNewswire/ -- Bio-Vascular, Inc. (NASDAQ:BVAS) today announced net income of $149,956, equal to 3 cents per share, for the first quarter ended Jan. 31, 1993, an increase of 143.1 percent from last year's first quarter when the company earned $61,676, or 1 cent per share. Net sales increased 28.7 percent to $1,149,570 from $893,135 last year.
 The company said it continued to experience very strong sales gains for its Dardik Biograft(R). Other contributors to the sales increase were two types of Peri-Guard(R) tissue patches and the Robicsek Vascular Probe(TM). Gross margin contracted somewhat to 57.3 percent of sales from 61.5 percent, reflecting the changing product mix and a higher proportion of international sales, which have lower margins.
 Bio-Vascular, Inc., based in St. Paul, is a manufacturer and marketer of proprietary consumable medical products for cardiac and vascular surgery.
 BIO-VASCULAR, INC.
 Statement of Operations
 Quarter Ended
 Jan.31,
 1993 1992
 Net sales $1,149,570 $893,135
 Cost of sales 490,607 343,441
 Operating expenses 603,457 542,543
 Income from operations 55,506 7,151
 Other income 97,978 54,525
 Income before
 income taxes 153,484 61,676
 Provision for
 income taxes (3,528) --
 Net income $149,956 $61,676
 Per common share:
 Net income $0.03 $0.01
 Weighted average
 number of common
 shares outstanding 5,556,983 5,556,082
 -0- 2/22/93
 /CONTACT: Curt Swenson of Swenson Falker Eilertsen, 612-371-0000, for Bio-Vascular; or Karen Gilles of Bio-Vascular, 612-631-3529/
 (BVAS)


CO: Bio-Vascular, Inc. ST: Minnesota IN: MTC SU: ERN

AL -- MN010 -- 0031 02/22/93 13:17 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 22, 1993
Words:280
Previous Article:DOLCO PACKAGING CORP. REPORTS FOURTH QUARTER RESULTS
Next Article:GENERAL MILLS DECLARES QUARTERLY DIVIDEND
Topics:


Related Articles
BIO-VASCULAR REPORTS FIRST QUARTER GAINS IN SALES AND NET INCOME
BIO-VASCULAR REPORTS GAINS IN THIRD QUARTER SALES, NET INCOME
BIO-VASCULAR REPORTS 2ND QUARTER RESULTS
BIO-VASCULAR REPORTS HIGHER INCOME IN THIRD QUARTER
BRADYCARDIA PACING, TACHYARRHYTHMIA DEVICE SALES HIGHLIGHT STRONG QUARTER FOR MEDTRONIC; EARNINGS UP 23.1 PCT.
MEDTRONIC EARNINGS PER SHARE RISE 24.2 PERCENT ON ACCELERATING WORLDWIDE SALES
MEDTRONIC EARNINGS PER SHARE RISE 24.2 PERCENT ON ACCELERATING WORLDWIDE SALES
BIO-VASCULAR REPORTS BREAK-EVEN RESULTS FOR SECOND QUARTER
Bio-Vascular Reports 1st Quarter Profit
Bio-Vascular Reduces Third-Quarter Loss to Near Break-Even Level as Revenues Increase 15 Percent

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters